Today’s Commitment. Tomorrow’s Cure.
Prism Health North Texas launched its Clinical Research Program in 2006 when the Peabody Health Center became a network clinical research site (CRS) for the National Institutes of Health’s (NIH) AIDS Clinical Trials Group (ACTG). From 2006 to 2025, we proudly served as an ACTG site, contributing to groundbreaking research and advancing care for people living with HIV.
In 2007, we expanded our commitment to innovative research by partnering with pharmaceutical companies to conduct industry-sponsored clinical trials. These collaborations have allowed us to broaden our focus to include HIV and other communicable diseases, and we continue to grow our efforts in clinical research today. Although we are no longer a CRS for the NIH as of 2025, our dedication to improving health outcomes through clinical trials remains stronger than ever.
PHNTX conducted clinical trials which have led to the FDA approval and/or expanded indications for 8 medications: Biktarvy, Pifeltro, Delstrigo, Cabenuva, Apretude, Trogarzo, Dovato, and Sunlenca.
If you have questions about PHNTX’s clinical research, you can explore the Frequently Asked Questions section on this page, call our main line at 214-521-5191 and ask to be transferred to the clinical research department, or email us at [email protected].